Low Tolerance for Transcriptional Variation at Cohesin Genes Is

Total Page:16

File Type:pdf, Size:1020Kb

Low Tolerance for Transcriptional Variation at Cohesin Genes Is Functional genomics J Med Genet: first published as 10.1136/jmedgenet-2020-107095 on 11 September 2020. Downloaded from ORIGINAL RESEARCH Low tolerance for transcriptional variation at cohesin genes is accompanied by functional links to disease- relevant pathways William Schierding ,1 Julia A Horsfield,2,3 Justin M O’Sullivan 1,3,4 ► Additional material is ABSTRACT of functional cohesin without eliminating it alto- published online only. To view Background: The cohesin complex plays an essential gether. Complete loss of cohesin is not tolerated please visit the journal online in healthy individuals.2 Thus, cohesin is haplo- (http:// dx. doi. org/ 10. 1136/ role in genome organisation and cell division. A full jmedgenet- 2020- 107095). complement of the cohesin complex and its regulators is insufficient such that normal tissue development important for normal development, since heterozygous and homeostasis requires that the concentrations 1Liggins Institute, The University mutations in genes encoding these components can of cohesin and its regulatory factors remain tightly of Auckland, Auckland, New be sufficient to produce a disease phenotype. The regulated. Zealand 2Department of Pathology, implication that genes encoding the cohesin subunits The human mitotic cohesin ring contains four Dunedin School of Medicine, or cohesin regulators must be tightly controlled and integral subunits: two structural maintenance University of Otago, Dunedin, resistant to variability in expression has not yet been proteins (SMC1A, SMC3), one stromalin HEAT- New Zealand 3 formally tested. repeat domain subunit (STAG1 or STAG2) and one Maurice Wilkins Centre 6 for Molecular Biodiscovery, Methods: Here, we identify spatial- regulatory kleisin subunit (RAD21). Genes encoding cohesin The University of Auckland, connections with potential to regulate expression of subunits are mutated in a wide range of cancers. Auckland, New Zealand cohesin loci (Mitotic: SMC1A, SMC3, STAG1, STAG2, Cohesin mutations are especially prevalent in acute 4 MRC Lifecourse Epidemiology RAD21/RAD21- AS; Meiotic: SMC1B, STAG3, REC8, myeloid leukaemia.7–9 Notably, STAG2 is 1 of just Unit, University of Southampton, RAD21L1), cohesin- ring support genes (NIPBL, MAU2, 12 genes mutated in four or more cancers,5 partic- Southampton, UK WAPL, PDS5A, PDS5B) and CTCF, including linking their ularly in bladder cancer, Ewing sarcoma, glioblas- 10 Correspondence to expression to that of other genes. We searched the toma and myeloid malignancies. Dr William Schierding, The genome- wide association studies (GWAS) catalogue for In meiotic cohesin, SMC1A is replaced by University of Auckland Liggins SNPs mapped or attributed to cohesin genes by GWAS SMC1B; STAG1/2 by STAG3 and RAD21 by Institute, Auckland 1142, New (GWAS- attributed) and the GTEx catalogue for SNPs REC8 or RAD21L1.1 Mutations in meiotic cohesin Zealand; mapped to cohesin genes by cis- regulatory variants subunits are associated with infertility in men,11 w. schierding@ auckland. ac. nz and Dr Julia A Horsfield, in one or more of 44 tissues across the human body chromosome segregation errors and primary 12 Department of Pathology, (expression quantitative trail locus- attributed). ovarian insufficiency in women. Dunedin School of Medicine, Results: Connections that centre on the cohesin ring Cohesin is loaded onto DNA by the SCC2/SCC4 University of Otago, Dunedin subunits provide evidence of coordinated regulation complex (encoded by the NIPBL and MAU2 genes, 9016, New Zealand; 1 http://jmg.bmj.com/ julia. horsfield@ otago. ac. nz that has little tolerance for perturbation. We used the respectively). Mutations in the cohesin loading CoDeS3D SNP- gene attribution methodology to identify factor NIPBL are associated with >65% cases of Received 14 April 2020 transcriptional changes across a set of genes coregulated Cornelia de Lange syndrome (CdLS). Remarkably, Revised 8 June 2020 with the cohesin loci that include biological pathways features associated with CdLS are observed with Accepted 20 June 2020 such as extracellular matrix production and proteasome- less than 30% depletion in NIPBL protein levels.13 mediated protein degradation. Remarkably, many of The release of cohesin from DNA is achieved by the genes that are coregulated with cohesin loci are WAPL, which opens up the interface connecting the themselves intolerant to loss- of- function. SMC3 and RAD21 subunits. The PDS5A/PDS5B on October 6, 2021 by guest. Protected copyright. Conclusions: The results highlight the importance cohesin associated subunits affect this process by of robust regulation of cohesin genes and implicate contacting cohesin to either maintain (with STAG1 novel pathways that may be important in the human and STAG2) or remove (with WAPL) the ring from cohesinopathy disorders. DNA.1 Spatial organisation and compaction of chro- mosomes in the nucleus involves non- random folding of DNA on different scales. The genome © Author(s) (or their INTRODUCTION is segregated into active A compartments and employer(s)) 2020. Re- use The cohesin complex has multiple essential roles inactive B compartments,14 inside which further permitted under CC BY- NC. No during cell division in mitosis and meiosis, genome organisation occurs into topologically associating commercial re- use. See rights and permissions. Published organisation, DNA damage repair and gene expres- domains (TADs) interspersed with genomic regions 1 14 by BMJ. sion. Mutations in genes that encode members of with fewer interactions. Cohesin participates in the cohesin complex, or its regulators, cause devel- genome organisation by mediating ‘loop extrusion’ To cite: Schierding W, opmental diseases known as the ‘cohesinopathies’ of DNA to form loops that anchor TAD boundaries. Horsfield JA, O’Sullivan JM. 2 J Med Genet Epub ahead of when present in the germline or contribute to the At TAD boundaries, cohesin colocalises with the 3–5 print: [please include Day development of cancer in somatic cells. CCCTC binding factor (CTCF) to form chromatin Month Year]. doi:10.1136/ Remarkably, cohesin mutations are almost always loops between convergent CTCF binding sites. jmedgenet-2020-107095 heterozygous and result in depletion of the amount Fine- scale genomic interactions include chromatin Schierding W, et al. J Med Genet 2020;0:1–9. doi:10.1136/jmedgenet-2020-107095 1 Functional genomics J Med Genet: first published as 10.1136/jmedgenet-2020-107095 on 11 September 2020. Downloaded from loops that mediate promoter- enhancer contacts. Notably, the and regulatory hubs). We also identify all variants within each time- specific and tissue- specific formation of the fine- scale loops gene locus that had a previously determined cis- eQTL (GTEx also requires cohesin.15–17 catalogue) to the cohesin gene (eQTL-attributed variant list). As The spatial organisation of the genome is particularly dynamic with the GWAS variants, we tested these variants for the pres- and susceptible to disruption during development. For example, ence of spatial-regulatory relationships involving genes outside changes to TAD boundaries are associated with developmental of the locus. Only a few of these eQTL-attributed variants are disorders.18 Furthermore, disruption of TAD boundaries by currently implicated in disease pathways, but their regulatory cohesin knockdown can lead to ectopic enhancer- promoter relationships with cohesin suggest that they may be significant interactions that result in changes in gene expression.19 Rewiring for cohesinopathy disorders. of the patterns of course and fine- scale chromatin interactions also contributes to cancer development,20–22 including the gener- ation of oncogenic chromosomal translocations.23 24 RESULTS Disease- associated genome- wide association study (GWAS) 140 genetic variants with regulatory potential are associated variants in non- coding DNA likely act through spatially organ- with cohesin loci ised hubs of regulatory control elements, each component of Mitotic cohesin genes (SMC1A, SMC3, STAG1, STAG2 and which contributes a small amount to the observed phenotype(s), RAD21), meiotic cohesin genes (SMC1B, STAG3, REC8 and as predicted by the omnigenic hypothesis.25 26 Non- coding muta- RAD21L1), cohesin support genes (WAPL, NIPBL, PDS5A, tions at cohesin and cohesin- associated factors were found by PDS5B and MAU2) and CTCF were investigated to determine GWAS (GWAS- attributed variants) to track with multiple pheno- if they contain non- coding genetic variants (SNPs) that make types.27 However, the impact of genetic variants located within contact in 3D with genes and therefore could directly affect gene cohesin and its associated genes has not yet been investigated expression (GWAS- attributed and eQTL-attributed; table 1, with respect to phenotype development. online supplementary table S1). We hypothesised that cohesin- associated pathologies can be A total of 106 GWAS-attributed genetic variants associated affected by subtle, combinatorial changes in the regulation of with disease were identified (methods) that mapped to a cohesin cohesin genes caused by common genetic variants within control gene (49 GWAS; 50 SNPs) or cohesin- associated (49 GWAS; 56 elements. Here, we link the 3D structure of the genome with SNPs) gene (online supplementary table S1). Twelve SNPs (blue, expression quantitative trail locus (eQTL) data to determine if online supplementary table S1) are not listed in the current GWAS variants attributed to cohesin genes affect their transcrip- GTEx SNP dictionary
Recommended publications
  • Meiotic Cohesin and Variants Associated with Human Reproductive Aging and Disease
    fcell-09-710033 July 27, 2021 Time: 16:27 # 1 REVIEW published: 02 August 2021 doi: 10.3389/fcell.2021.710033 Meiotic Cohesin and Variants Associated With Human Reproductive Aging and Disease Rachel Beverley1, Meredith L. Snook1 and Miguel Angel Brieño-Enríquez2* 1 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States, 2 Magee-Womens Research Institute, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States Successful human reproduction relies on the well-orchestrated development of competent gametes through the process of meiosis. The loading of cohesin, a multi- protein complex, is a key event in the initiation of mammalian meiosis. Establishment of sister chromatid cohesion via cohesin rings is essential for ensuring homologous recombination-mediated DNA repair and future proper chromosome segregation. Cohesin proteins loaded during female fetal life are not replenished over time, and therefore are a potential etiology of age-related aneuploidy in oocytes resulting in Edited by: decreased fecundity and increased infertility and miscarriage rates with advancing Karen Schindler, Rutgers, The State University maternal age. Herein, we provide a brief overview of meiotic cohesin and summarize of New Jersey, United States the human genetic studies which have identified genetic variants of cohesin proteins and Reviewed by: the associated reproductive phenotypes
    [Show full text]
  • Atrec8 and Atscc3 Are Essential to the Monopolar Orientation of the Kinetochores During Meiosis
    Research Article 4621 AtREC8 and AtSCC3 are essential to the monopolar orientation of the kinetochores during meiosis Liudmila Chelysheva, Stéphanie Diallo*, Daniel Vezon, Ghislaine Gendrot, Nathalie Vrielynck, Katia Belcram, Nathalie Rocques, Angustias Márquez-Lema‡, Anuj M. Bhatt§, Christine Horlow, Raphaël Mercier, Christine Mézard and Mathilde Grelon¶ Institut Jean-Pierre Bourgin, Station de Génétique et d’Amélioration des Plantes, INRA de Versailles, Route de Saint-Cyr, 78026 Versailles CEDEX, France *Present address: Laboratoire de Microbiologie du Froid UPRES 2123, 55 Rue Saint-Germain, 27000 Evreux, France ‡Present address: Instituto de Agricultura Sostenible (CSIC), Apartado 4084, E-14080, Córdoba, Spain §Present address: Department of Plant Sciences, University of Oxford, South Parks Road, Oxford, OX1 3RB, UK ¶Author for correspondence (e-mail: [email protected]) Accepted 13 July 2005 Journal of Cell Science 118, 4621-4632 Published by The Company of Biologists 2005 doi:10.1242/jcs.02583 Summary The success of the first meiotic division relies (among other in meiotic nuclei as early as interphase, and bound to the factors) on the formation of bivalents between homologous chromosome axis from early leptotene through to anaphase chromosomes, the monopolar orientation of the sister I. We show here that both AtREC8 and AtSCC3 are kinetochores at metaphase I and the maintenance of necessary not only to maintain centromere cohesion at centromeric cohesion until the onset of anaphase II. The anaphase I, but also for the monopolar orientation of the meiotic cohesin subunit, Rec8 has been reported to be one kinetochores during the first meiotic division. We also of the key players in these processes, but its precise role in found that AtREC8 is involved in chromosome axis kinetochore orientation is still under debate.
    [Show full text]
  • Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
    REPORTS mean difference for all rubric score elements was ing becomes a more commonly supported facet 18. C. L. Townsend, E. Heit, Mem. Cognit. 39, 204 (2011). rejected. Univariate statistical tests of the observed of STEM graduate education then students’ in- 19. D. F. Feldon, M. Maher, B. Timmerman, Science 329, 282 (2010). mean differences between the teaching-and- structional training and experiences would alle- 20. B. Timmerman et al., Assess. Eval. High. Educ. 36,509 research and research-only conditions indicated viate persistent concerns that current programs (2011). significant results for the rubric score elements underprepare future STEM faculty to perform 21. No outcome differences were detected as a function of “testability of hypotheses” [mean difference = their teaching responsibilities (28, 29). the type of teaching experience (TA or GK-12) within the P sample population participating in both research and 0.272, = 0.006; CI = (.106, 0.526)] with the null teaching. hypothesis rejected in 99.3% of generated data References and Notes 22. Materials and methods are available as supporting samples (Fig. 1) and “research/experimental de- 1. W. A. Anderson et al., Science 331, 152 (2011). material on Science Online. ” P 2. J. A. Bianchini, D. J. Whitney, T. D. Breton, B. A. Hilton-Brown, 23. R. L. Johnson, J. Penny, B. Gordon, Appl. Meas. Educ. 13, sign [mean difference = 0.317, = 0.002; CI = Sci. Educ. 86, 42 (2001). (.106, 0.522)] with the null hypothesis rejected in 121 (2000). 3. C. E. Brawner, R. M. Felder, R. Allen, R. Brent, 24. R. J. A. Little, J.
    [Show full text]
  • Identification of Key Pathways and Genes in Endometrial Cancer Using Bioinformatics Analyses
    ONCOLOGY LETTERS 17: 897-906, 2019 Identification of key pathways and genes in endometrial cancer using bioinformatics analyses YAN LIU, TENG HUA, SHUQI CHI and HONGBO WANG Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, P.R. China Received March 16, 2018; Accepted October 12, 2018 DOI: 10.3892/ol.2018.9667 Abstract. Endometrial cancer (EC) is one of the most Introduction common gynecological cancer types worldwide. However, to the best of our knowledge, its underlying mechanisms Endometrial carcinoma (EC) is one of the most common remain unknown. The current study downloaded three mRNA gynecological cancer types, with increasing global incidence and microRNA (miRNA) datasets of EC and normal tissue in recent years (1). A total of 60,050 cases of EC and 10,470 samples, GSE17025, GSE63678 and GSE35794, from the EC-associated cases of mortality were reported in the USA in Gene Expression Omnibus to identify differentially expressed 2016 (1), which was markedly higher than the 2012 statistics genes (DEGs) and miRNAs (DEMs) in EC tumor tissues. of 47,130 cases and 8,010 mortalities (2). Although numerous The DEGs and DEMs were then validated using data from studies have been conducted to investigate the mechanisms of The Cancer Genome Atlas and subjected to gene ontology endometrial tumorigenesis and development, to the best of our and Kyoto Encyclopedia of Genes and Genomes pathway knowledge, the exact etiology remains unknown. Understanding analysis. STRING and Cytoscape were used to construct a the potential molecular mechanisms underlying EC initiation protein-protein interaction network and the prognostic effects and progression is of great clinical significance.
    [Show full text]
  • Evolution, Expression and Meiotic Behavior of Genes Involved in Chromosome Segregation of Monotremes
    G C A T T A C G G C A T genes Article Evolution, Expression and Meiotic Behavior of Genes Involved in Chromosome Segregation of Monotremes Filip Pajpach , Linda Shearwin-Whyatt and Frank Grützner * School of Biological Sciences, The University of Adelaide, Adelaide, SA 5005, Australia; fi[email protected] (F.P.); [email protected] (L.S.-W.) * Correspondence: [email protected] Abstract: Chromosome segregation at mitosis and meiosis is a highly dynamic and tightly regulated process that involves a large number of components. Due to the fundamental nature of chromosome segregation, many genes involved in this process are evolutionarily highly conserved, but duplica- tions and functional diversification has occurred in various lineages. In order to better understand the evolution of genes involved in chromosome segregation in mammals, we analyzed some of the key components in the basal mammalian lineage of egg-laying mammals. The chromosome passenger complex is a multiprotein complex central to chromosome segregation during both mitosis and meio- sis. It consists of survivin, borealin, inner centromere protein, and Aurora kinase B or C. We confirm the absence of Aurora kinase C in marsupials and show its absence in both platypus and echidna, which supports the current model of the evolution of Aurora kinases. High expression of AURKBC, an ancestor of AURKB and AURKC present in monotremes, suggests that this gene is performing all necessary meiotic functions in monotremes. Other genes of the chromosome passenger complex complex are present and conserved in monotremes, suggesting that their function has been preserved Citation: Pajpach, F.; in mammals.
    [Show full text]
  • The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
    cancers Review The Mutational Landscape of Myeloid Leukaemia in Down Syndrome Carini Picardi Morais de Castro 1, Maria Cadefau 1,2 and Sergi Cuartero 1,2,* 1 Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, 08916 Badalona, Spain; [email protected] (C.P.M.d.C); [email protected] (M.C.) 2 Germans Trias i Pujol Research Institute (IGTP), Campus Can Ruti, 08916 Badalona, Spain * Correspondence: [email protected] Simple Summary: Leukaemia occurs when specific mutations promote aberrant transcriptional and proliferation programs, which drive uncontrolled cell division and inhibit the cell’s capacity to differentiate. In this review, we summarize the most frequent genetic lesions found in myeloid leukaemia of Down syndrome, a rare paediatric leukaemia specific to individuals with trisomy 21. The evolution of this disease follows a well-defined sequence of events and represents a unique model to understand how the ordered acquisition of mutations drives malignancy. Abstract: Children with Down syndrome (DS) are particularly prone to haematopoietic disorders. Paediatric myeloid malignancies in DS occur at an unusually high frequency and generally follow a well-defined stepwise clinical evolution. First, the acquisition of mutations in the GATA1 transcription factor gives rise to a transient myeloproliferative disorder (TMD) in DS newborns. While this condition spontaneously resolves in most cases, some clones can acquire additional mutations, which trigger myeloid leukaemia of Down syndrome (ML-DS). These secondary mutations are predominantly found in chromatin and epigenetic regulators—such as cohesin, CTCF or EZH2—and Citation: de Castro, C.P.M.; Cadefau, in signalling mediators of the JAK/STAT and RAS pathways.
    [Show full text]
  • Redundant and Specific Roles of Cohesin STAG Subunits in Chromatin Looping and Transcriptional Control
    Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Research Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control Valentina Casa,1,6 Macarena Moronta Gines,1,6 Eduardo Gade Gusmao,2,3,6 Johan A. Slotman,4 Anne Zirkel,2 Natasa Josipovic,2,3 Edwin Oole,5 Wilfred F.J. van IJcken,1,5 Adriaan B. Houtsmuller,4 Argyris Papantonis,2,3 and Kerstin S. Wendt1 1Department of Cell Biology, Erasmus MC, 3015 GD Rotterdam, The Netherlands; 2Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany; 3Institute of Pathology, University Medical Center, Georg-August University of Göttingen, 37075 Göttingen, Germany; 4Optical Imaging Centre, Erasmus MC, 3015 GD Rotterdam, The Netherlands; 5Center for Biomics, Erasmus MC, 3015 GD Rotterdam, The Netherlands Cohesin is a ring-shaped multiprotein complex that is crucial for 3D genome organization and transcriptional regulation during differentiation and development. It also confers sister chromatid cohesion and facilitates DNA damage repair. Besides its core subunits SMC3, SMC1A, and RAD21, cohesin in somatic cells contains one of two orthologous STAG sub- units, STAG1 or STAG2. How these variable subunits affect the function of the cohesin complex is still unclear. STAG1- and STAG2-cohesin were initially proposed to organize cohesion at telomeres and centromeres, respectively. Here, we uncover redundant and specific roles of STAG1 and STAG2 in gene regulation and chromatin looping using HCT116 cells with an auxin-inducible degron (AID) tag fused to either STAG1 or STAG2. Following rapid depletion of either subunit, we perform high-resolution Hi-C, gene expression, and sequential ChIP studies to show that STAG1 and STAG2 do not co-occupy in- dividual binding sites and have distinct ways by which they affect looping and gene expression.
    [Show full text]
  • Download Download
    Supplementary Figure S1. Results of flow cytometry analysis, performed to estimate CD34 positivity, after immunomagnetic separation in two different experiments. As monoclonal antibody for labeling the sample, the fluorescein isothiocyanate (FITC)- conjugated mouse anti-human CD34 MoAb (Mylteni) was used. Briefly, cell samples were incubated in the presence of the indicated MoAbs, at the proper dilution, in PBS containing 5% FCS and 1% Fc receptor (FcR) blocking reagent (Miltenyi) for 30 min at 4 C. Cells were then washed twice, resuspended with PBS and analyzed by a Coulter Epics XL (Coulter Electronics Inc., Hialeah, FL, USA) flow cytometer. only use Non-commercial 1 Supplementary Table S1. Complete list of the datasets used in this study and their sources. GEO Total samples Geo selected GEO accession of used Platform Reference series in series samples samples GSM142565 GSM142566 GSM142567 GSM142568 GSE6146 HG-U133A 14 8 - GSM142569 GSM142571 GSM142572 GSM142574 GSM51391 GSM51392 GSE2666 HG-U133A 36 4 1 GSM51393 GSM51394 only GSM321583 GSE12803 HG-U133A 20 3 GSM321584 2 GSM321585 use Promyelocytes_1 Promyelocytes_2 Promyelocytes_3 Promyelocytes_4 HG-U133A 8 8 3 GSE64282 Promyelocytes_5 Promyelocytes_6 Promyelocytes_7 Promyelocytes_8 Non-commercial 2 Supplementary Table S2. Chromosomal regions up-regulated in CD34+ samples as identified by the LAP procedure with the two-class statistics coded in the PREDA R package and an FDR threshold of 0.5. Functional enrichment analysis has been performed using DAVID (http://david.abcc.ncifcrf.gov/)
    [Show full text]
  • NVND-2019 Book
    2nd International Conference on Neurovascular and Neurodegenerative Diseases October 28-30 2019 Media Partner Venue Paris Marriott Charles de Gaulle Airport Hotel 5 Allee du Verger, Zone Hoteliere Roissy en France, 95700 France Day- 1 Monday | October 28, 2019 Keynote Presentations Cerebrovascular Lesions in Pick Complex Diseases: A Neuropathological Study with a 7.0-tesla Magnetic Resonance Imaging Jacques De Reuck Université Lille 2, INSERM U1171, Degenerative & Vascular Cognitive Disorders, CHR Lille, France Abstract Introduction: Pick complex refers to a spectrum of diseases that have in common the presence of tau inclusions. The main neuropathological phenotypes comprise tau-frontotemporal lobar degeneration (Tau-FTLD), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). The present neuropathological study investigates their incidence of cerebrovascular lesions. Material and Methods: seventy patients underwent an autopsy and post-mortem MRI. The brains consisted of 14 with Tau-FTLD, 22 with PSP, 6 with CBD and 28 controls, who had no history of a brain disease. A whole coronal section of a cerebral hemisphere, at the level of the mamillary body, was taken for the semi-quantitative evaluation of the small cerebrovascular lesions such as white matter changes (WMCs), cortical micro-bleeds (CoMBs), and cortical micro-infarcts (CoMIs). In addition the severity and the distribution of WMCs, CoMIs and CoMBs were examined with 7.0-tesla MRI on three coronal sections of a cerebral hemisphere. Results: on neuropathological examination severe WMCs and more CoMBs are observed in Tau-FTLD, while the latter are also more frequent in CBD. The MRI examination shows that severe WMCs are present in the frontal sections not only of the Tau-FTLD but also to a lesser degree of the PSP and CBD brains.
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Table SI. Genes Upregulated ≥ 2-Fold by MIH 2.4Bl Treatment Affymetrix ID
    Table SI. Genes upregulated 2-fold by MIH 2.4Bl treatment Fold UniGene ID Description Affymetrix ID Entrez Gene Change 1558048_x_at 28.84 Hs.551290 231597_x_at 17.02 Hs.720692 238825_at 10.19 93953 Hs.135167 acidic repeat containing (ACRC) 203821_at 9.82 1839 Hs.799 heparin binding EGF like growth factor (HBEGF) 1559509_at 9.41 Hs.656636 202957_at 9.06 3059 Hs.14601 hematopoietic cell-specific Lyn substrate 1 (HCLS1) 202388_at 8.11 5997 Hs.78944 regulator of G-protein signaling 2 (RGS2) 213649_at 7.9 6432 Hs.309090 serine and arginine rich splicing factor 7 (SRSF7) 228262_at 7.83 256714 Hs.127951 MAP7 domain containing 2 (MAP7D2) 38037_at 7.75 1839 Hs.799 heparin binding EGF like growth factor (HBEGF) 224549_x_at 7.6 202672_s_at 7.53 467 Hs.460 activating transcription factor 3 (ATF3) 243581_at 6.94 Hs.659284 239203_at 6.9 286006 Hs.396189 leucine rich single-pass membrane protein 1 (LSMEM1) 210800_at 6.7 1678 translocase of inner mitochondrial membrane 8 homolog A (yeast) (TIMM8A) 238956_at 6.48 1943 Hs.741510 ephrin A2 (EFNA2) 242918_at 6.22 4678 Hs.319334 nuclear autoantigenic sperm protein (NASP) 224254_x_at 6.06 243509_at 6 236832_at 5.89 221442 Hs.374076 adenylate cyclase 10, soluble pseudogene 1 (ADCY10P1) 234562_x_at 5.89 Hs.675414 214093_s_at 5.88 8880 Hs.567380; far upstream element binding protein 1 (FUBP1) Hs.707742 223774_at 5.59 677825 Hs.632377 small nucleolar RNA, H/ACA box 44 (SNORA44) 234723_x_at 5.48 Hs.677287 226419_s_at 5.41 6426 Hs.710026; serine and arginine rich splicing factor 1 (SRSF1) Hs.744140 228967_at 5.37
    [Show full text]
  • Rabbit Anti-CDCA5/FITC Conjugated Antibody
    SunLong Biotech Co.,LTD Tel: 0086-571- 56623320 Fax:0086-571- 56623318 E-mail:[email protected] www.sunlongbiotech.com Rabbit Anti-CDCA5/FITC Conjugated antibody SL7717R-FITC Product Name: Anti-CDCA5/FITC Chinese Name: FITC标记的细胞分裂周期相关蛋白5抗体 Alias: Cell division cycle associated protein 5; MGC16386; p35; Sororin; CDCA5_HUMAN. Organism Species: Rabbit Clonality: Polyclonal React Species: Human,Mouse,Rat,Dog,Pig,Cow,Horse,Rabbit, Flow-Cyt=1:50-200IF=1:50-200 Applications: not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. Molecular weight: 28kDa Form: Lyophilized or Liquid Concentration: 1mg/ml immunogen: KLH conjugated synthetic peptide derived from human CDCA5 Lsotype: IgG Purification: affinity purified by Protein A Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibodywww.sunlongbiotech.com is stable at room temperature for at least one month and for greater than a year Storage: when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. background: Sororin, also designated cell division cycle-associated protein 5 (CDCA5) or p35, functions as a regulator of sister chromatid cohesion during mitosis. It interacts with the APC/C complex and is found in a complex consisting of cohesion components SCC- 112, MC1L1, SMC3L1, RAD21 and APRIN. The deduced human and mouse Sororin Product Detail: proteins consist of 252 and 264 amino acid residues, respectively, and both contain a KEN box for APC-dependent ubiquitination.
    [Show full text]